Urenco ChemPlants owns and will operate our most recent nuclear new build, Urenco’s Tails Management Facility.
Urenco ChemPlants Read moreSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report06 March 2024
Nuclear energy is amongst the headlines to come out of the Spring Budget statement made by the UK Government.
A Urenco spokesperson said:
"We welcome today’s announcement by the Chancellor, confirming that the government will purchase the Wylfa site in Ynys Môn and the Oldbury-on-Severn site in South Gloucestershire for potential nuclear new-builds.
"We also welcome the announcement that Great British Nuclear will begin the next phase of the Small Modular Reactor selection process, with companies now invited to submit their initial tender responses by June.
"Both announcements are a vital step in delivering the 24 GW of nuclear by 2050 ambition and will support the development of fuel production and manufacturing capabilities in the UK. We look forward to hearing further developments and engaging with Government and industry to support this progress."
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries